ABSTRACT
In the recent past, the resonance energy transfer studies using metallic nanoparticles has become a matter of quintessence in modern technology, which considerably extends its applications in probing specific biological and chemical processes. In the present study, metallic-silver nanoparticles of 2-4 nm (diameter) capped with hexanethiol ligand are developed and dispersed in ferroelectric liquid crystal (FLC). The morphology of nanoparticles was characterized using HR-TEM and SEM techniques. Furthermore, a systematic study of energy transfer between the host FLC material (as donors) and metallic-silver nanoparticles (as acceptors) has been explored employing steady state and time resolved fluorescence spectroscopic techniques. The nanoparticle based surface energy transfer (NSET) parameters viz., transfer efficiency, transfer rate, and proximity distance between donor and acceptor, have been determined for NSET couples (FLC material-metallic-silver nanoparticle) composites. It is observed that various NSET parameters and quenching efficiency follow a linear dependence on the concentration of metallic-silver nanoparticles in host FLC material. The nonradiative energy transfer and superquenching effect were analyzed with the help of Stern-Volmer plots. The impact of present study about superquenching effect of the silver nanoparticles can be used for sensing applications that require high degree sensitivity.
ABSTRACT
A series of 4-amino-2-(substituted)-5-(substituted)aryl-6-[(substituted)aryl)-amino]pyrimidines was designed based on the triangular pharmacophoric requirements for histamine H1-receptor antagonists. The designed molecules were synthesized by condensation of arylacetonitriles with respective arylisothiocyanates to form corresponding acrylonitriles followed by cyclocondensation with carboxamidines to afford substituted pyrimidines. All compounds were screened for their histamine H1-receptor antagonistic activity using the model "Inhibition of the isotonic contraction induced by histamine on isolated guinea pig ileum". Target compounds were also evaluated for their sedative potential as well as their anticholinergic activities as these two are known to be the common adverse effects of histamine H1-receptor antagonists. Compounds 2h, 2i, 2j and 2k exhibited potent histamine H1-receptor antagonistic activity, which was found to be comparable with the standard drug, cetirizine (CAS 83881-51-0) and more potent than the conventional drug mepyramine (CAS 91-84-9). Some of the compounds have displayed very low sedative potential compared to diphenhydramine (CAS 58-73-1), but was found higher than cetirizine. None of them showed anticholinergic activity indicating potentialities of this series to be developed as second-generation histamine H1-receptor antagonists.
